Zehirlenmelerde İntralipid Tedavi Yaklaşımı

Yazarlar

Halil Ölmez

Özet

İntralipid emülsiyon (İLE) tedavisi, lipid emülsiyonlarının intravenöz olarak verilmesiyle toksik maddelerin vücuda zarar vermesini engellemeye dayanan bir yöntemdir. Başlangıçta beslenme desteği amacıyla kullanılan bu karışımlar, 1998 yılında yapılan deneysel çalışmalarla bupivakain toksisitesine bağlı kardiyak arresti geri döndürebildiğinin gösterilmesi sonucu lokal anestezik toksisitesinde çığır açan yeni bir tedavi yaklaşımı haline gelmiştir. Sonraki yıllarda lokal anestezik dışındaki lipofilik ilaç zehirlenmelerinde de hemodinamik açıdan instabil ve standart tedavilere yanıt vermeyen vakalarda kullanımı giderek yaygınlaşmıştır. Piyasada sıkça tercih edilen %20'lik İntralipid formülasyonu soya yağı, gliserin, yumurta fosfolipidleri ve sudan oluşmaktadır. İLE tedavisinin etki mekanizması tam olarak netleşmemekle birlikte en öne çıkan görüş, emülsiyonun kanda lipofilik ilaçları bağlayarak dokulardan uzaklaştırdığını savunan Lipid Sink teorisidir. Bunun yanı sıra miyokard kontraktilitesini artırma ve iyon kanallarını düzenleme gibi mekanizmalar da öne sürülmektedir. İLE'nin en temel endikasyonu lokal anesteziklerin sistemik toksisitesidir; diğer zehirlenmelerde ise ilk basamak tedavi olmayıp dirençli olgularda denenmelidir. Tedavi sürecinde rebound etki, laboratuvar testlerinde hatalı sonuçlar, enfeksiyon, hemodiyaliz filtre tıkanması, anafilaksi ve tromboflebit gibi birtakım komplikasyonlar gelişebilir. İLE uygulamasında genellikle 1,5 ml/kg İV bolus sonrasında 0,25-0,50 ml/kg/dakika idame dozu önerilmekte, tahliller için kan örneklerinin tedavi öncesinde alınması büyük önem taşımaktadır.

Intralipid emulsion (ILE) therapy is a method based on the intravenous administration of lipid emulsions to prevent toxic substances from harming the body. Initially used for nutritional support, these mixtures became a novel treatment approach in local anesthetic toxicity after experimental studies in 1998 demonstrated that intravenous lipid emulsion could reverse cardiac arrest caused by bupivacaine toxicity. In subsequent years, its use expanded to non-local anesthetic lipophilic drug poisonings in hemodynamically unstable cases unresponsive to standard therapies. The commercially widely used 20% Intralipid formulation consists of soybean oil, glycerin, egg phospholipids, and water. Although the exact mechanism of action of ILE therapy remains unconfirmed, the prominent view is the "Lipid Sink" theory, which posits that the emulsion binds lipophilic drugs in the blood and removes them from target tissues. Additional proposed mechanisms include increasing myocardial contractility and modulating ion channels. The primary indication for ILE is local anesthetic systemic toxicity; it is not a first-line treatment for other drug poisonings but should be attempted in refractory cases. During treatment, complications such as rebound effects, laboratory test interferences, infection, hemodialysis filter clogging, anaphylaxis, and thrombophlebitis may occur. ILE administration typically involves a 1.5 ml/kg IV bolus followed by a maintenance dose of 0.25-0.50 ml/kg/min, with prior collection of blood samples for laboratory tests being highly critical.

Referanslar

Weinberg, G.L., T. VadeBoncouer, G.A. Ramaraju, M.F. Garcia-Amaro ve M.J. Cwik, Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. Anesthesiology, 1998. 88(4): ss. 1071-5.

Rosenblatt, Meg A., M. Abel, Gregory W. Fischer, Chad J. Itzkovich ve James B. Eisenkraft, Successful Use of a 20% Lipid Emulsion to Resuscitate a Patient after a Presumed Bupivacaine-related Cardiac Arrest. Anesthesiology, 2006. 105(1): ss. 217-218.

Sirianni, A.J., K.C. Osterhoudt, D.P. Calello, A.A. Muller, M.R. Waterhouse, M.B. Goodkin ve ark., Use of lipid emulsion in the resuscitation of a patient with prolonged cardiovascular collapse after overdose of bupropion and lamotrigine. Ann Emerg Med, 2008. 51(4): ss. 412-5, 415.e1.

Fettiplace, M.R. ve G. Weinberg, The Mechanisms Underlying Lipid Resuscitation Therapy. Regional Anesthesia & Pain Medicine, 2018. 43(2): ss. 138-149.

Stehr, S.N., A. Pexa, S. Hannack, A. Heintz, A.R. Heller, A. Deussen ve ark., Insulin effects on myocardial function and bioenergetics in L-bupivacaine toxicity in the isolated rat heart. European journal of anaesthesiology, 2007. 24(4): ss. 340-346.

Fernandez, A.L., J.A. Lee, L. Rahilly, L. Hovda, A.G. Brutlag ve K. Engebretsen, The use of intravenous lipid emulsion as an antidote in veterinary toxicology. J Vet Emerg Crit Care (San Antonio), 2011. 21(4): ss. 309-20.

Cave, G. ve M.G. Harvey, Should we consider the infusion of lipid emulsion in the resuscitation of poisoned patients? Crit Care, 2014. 18(5): ss. 457.

Neal, J.M., M.F. Mulroy ve G.L. Weinberg, American Society of Regional Anesthesia and Pain Medicine checklist for managing local anesthetic systemic toxicity: 2012 version. Reg Anesth Pain Med, 2012. 37(1): ss. 16-8.

Hoegberg, L.C., T.C. Bania, V. Lavergne, B. Bailey, A.F. Turgeon, S.H. Thomas ve ark., Systematic review of the effect of intravenous lipid emulsion therapy for local anesthetic toxicity. Clin Toxicol (Phila), 2016. 54(3): ss. 167-93.

Leskiw, U. ve G.L. Weinberg, Lipid resuscitation for local anesthetic toxicity: is it really lifesaving? Curr Opin Anaesthesiol, 2009. 22(5): ss. 667-71.

Grunbaum, A.M., B.M. Gilfix, S. Gosselin ve D.W. Blank, Analytical interferences resulting from intravenous lipid emulsion. Clinical Toxicology, 2012. 50(9): ss. 812-817.

McClave, S.A., R.G. Martindale, V.W. Vanek, M. McCarthy, P. Roberts, B. Taylor ve ark., Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr, 2009. 33(3): ss. 277-316.

Bayram, B., Zehirlenmelerde İntravenöz Lipid Emülsiyonları. 2018, https://www.acilci.net/zehirlenmelerde-intravenoz-lipid-emulsiyonlari/: Acilci.Net.

Turner-Lawrence, D.E. ve W. Kerns Ii, Intravenous fat emulsion: a potential novel antidote. J Med Toxicol, 2008. 4(2): ss. 109-14.

Cave, G., M. Harvey, J. Willers, D. Uncles, T. Meek, J. Picard ve ark., LIPAEMIC report: results of clinical use of intravenous lipid emulsion in drug toxicity reported to an online lipid registry. J Med Toxicol, 2014. 10(2): ss. 133-42.

Levine, M., A.B. Skolnik, A.-M. Ruha, A. Bosak, N. Menke ve A.F. Pizon, Complications Following Antidotal Use of Intravenous Lipid Emulsion Therapy. Journal of Medical Toxicology, 2014. 10(1): ss. 10-14.

Fettiplace, M.R., R. Ripper, K. Lis, D.L. Feinstein, I. Rubinstein ve G. Weinberg, Intraosseous lipid emulsion: an effective alternative to IV delivery in emergency situations. Crit Care Med, 2014. 42(2): ss. e157-60.

İndir

Yayınlanan

6 Nisan 2021

Lisans

Lisans